GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,577,000 | -82.5% | 11,881 | -90.7% | 0.17% | -83.9% |
| Q4 2020 | $14,759,000 | +58.8% | 127,885 | +33.9% | 1.05% | +38.9% |
| Q3 2020 | $9,297,000 | -17.8% | 95,499 | +3.6% | 0.75% | -32.5% |
| Q2 2020 | $11,311,000 | +17.1% | 92,169 | -16.5% | 1.12% | +1.0% |
| Q1 2020 | $9,660,000 | -11.9% | 110,317 | +5.2% | 1.11% | -1.9% |
| Q4 2019 | $10,961,000 | +40.1% | 104,834 | +54.1% | 1.13% | +26.1% |
| Q3 2019 | $7,824,000 | -33.0% | 68,019 | +0.5% | 0.89% | -34.6% |
| Q2 2019 | $11,670,000 | +6.5% | 67,695 | +4.1% | 1.37% | +0.1% |
| Q1 2019 | $10,957,000 | +404.9% | 64,998 | +191.7% | 1.36% | +475.9% |
| Q4 2018 | $2,170,000 | -45.5% | 22,282 | -3.3% | 0.24% | -34.5% |
| Q3 2018 | $3,982,000 | +24.3% | 23,054 | +0.4% | 0.36% | +20.7% |
| Q2 2018 | $3,204,000 | – | 22,963 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |